NEW YORK, Jan. 04, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Sonoco Products Company (NYSE:SON), Argos Therapeutics, Inc. (NASDAQ:ARGS), CDW Corporation (NASDAQ:CDW), Cenveo Inc (NASDAQ:CVO), CoBiz Financial Inc. (NASDAQ:COBZ), and Oppenheimer Holdings, Inc. (NYSE:OPY), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research. 

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

SON DOWNLOAD: http://Fundamental-Markets.com/register/?so=SON
ARGS DOWNLOAD: http://Fundamental-Markets.com/register/?so=ARGS
CDW DOWNLOAD: http://Fundamental-Markets.com/register/?so=CDW
CVO DOWNLOAD: http://Fundamental-Markets.com/register/?so=CVO
COBZ DOWNLOAD: http://Fundamental-Markets.com/register/?so=COBZ
OPY DOWNLOAD: http://Fundamental-Markets.com/register/?so=OPY

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Sonoco Products Company (NYSE:SON), Argos Therapeutics, Inc. (NASDAQ:ARGS), CDW Corporation (NASDAQ:CDW), Cenveo Inc (NASDAQ:CVO), CoBiz Financial Inc. (NASDAQ:COBZ), and Oppenheimer Holdings, Inc. (NYSE:OPY) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed January 2nd, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

SONOCO PRODUCTS COMPANY (SON) REPORT OVERVIEW

Sonoco Products' Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Sonoco Products reported revenue of $1,324.63MM vs $1,208.72MM (up 9.59%) and basic earnings per share $0.73 vs $0.65 (up 12.31%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, Sonoco Products reported revenue of $4,782.88MM vs $4,964.37MM (down 3.66%) and basic earnings per share $2.83 vs $2.46 (up 15.04%). Sonoco Products is expected to report earnings on February 8th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.62. The estimated EPS forecast for the next fiscal year is $3.06 and is expected to report on February 8th, 2018.

To read the full Sonoco Products Company (SON) report, download it here: http://Fundamental-Markets.com/register/?so=SON

-----------------------------------------

ARGOS THERAPEUTICS, INC. (ARGS) REPORT OVERVIEW

Argos Therapeutics' Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Argos Therapeutics reported revenue of $0.05MM vs $0.15MM (down 63.56%) and basic earnings per share -$0.10 vs -$0.32. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Argos Therapeutics reported revenue of $0.95MM vs $0.52MM (up 82.42%) and basic earnings per share -$1.66 vs -$3.66. Argos Therapeutics is expected to report earnings on March 15th, 2018. The report will be for the fiscal period ending December 31st, 2017.

To read the full Argos Therapeutics, Inc. (ARGS) report, download it here: http://Fundamental-Markets.com/register/?so=ARGS

-----------------------------------------

CDW CORPORATION (CDW) REPORT OVERVIEW

CDW's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, CDW reported revenue of $4,033.90MM vs $3,708.20MM (up 8.78%) and basic earnings per share $0.84 vs $0.78 (up 7.69%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, CDW reported revenue of $13,981.90MM vs $12,988.70MM (up 7.65%) and basic earnings per share $2.59 vs $2.37 (up 9.28%). CDW is expected to report earnings on February 6th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.81. The estimated EPS forecast for the next fiscal year is $4.09 and is expected to report on February 6th, 2018.

To read the full CDW Corporation (CDW) report, download it here: http://Fundamental-Markets.com/register/?so=CDW

-----------------------------------------

CENVEO INC (CVO) REPORT OVERVIEW

Cenveo's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Cenveo reported revenue of $329.51MM vs $382.68MM (down 13.89%) and basic earnings per share -$3.27 vs $1.10. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Cenveo reported revenue of $1,660.00MM vs $1,741.78MM (down 4.70%) and basic earnings per share $7.97 vs -$3.64. Cenveo is expected to report earnings on February 28th, 2018. The report will be for the fiscal period ending December 31st, 2017.

To read the full Cenveo Inc (CVO) report, download it here: http://Fundamental-Markets.com/register/?so=CVO

-----------------------------------------

COBIZ FINANCIAL INC. (COBZ) REPORT OVERVIEW

CoBiz Financial's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, CoBiz Financial reported interest income of $36.95MM vs $32.31MM (up 14.36%) and basic earnings per share $0.27 vs $0.25 (up 8.00%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, CoBiz Financial reported interest income of $127.78MM vs $121.27MM (up 5.37%) and basic earnings per share $0.84 vs $0.63 (up 33.33%). CoBiz Financial is expected to report earnings on January 25th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.21. The estimated EPS forecast for the next fiscal year is $1.19 and is expected to report on January 25th, 2018.

To read the full CoBiz Financial Inc. (COBZ) report, download it here: http://Fundamental-Markets.com/register/?so=COBZ

-----------------------------------------

OPPENHEIMER HOLDINGS, INC. (OPY) REPORT OVERVIEW

Oppenheimer's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Oppenheimer reported revenue of $226.22MM vs $211.80MM (up 6.81%) and basic earnings per share $0.59 vs -$0.05. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Oppenheimer reported revenue of $857.78MM vs $897.80MM (down 4.46%) and basic earnings per share -$0.09 vs $0.14. Oppenheimer is expected to report earnings on January 26th, 2018. The report will be for the fiscal period ending December 31st, 2017.

To read the full Oppenheimer Holdings, Inc. (OPY) report, download it here: http://Fundamental-Markets.com/register/?so=OPY

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at [email protected].

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: [email protected]

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at [email protected].

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.